Hengrui Pharma (01276) has issued an announcement regarding its share repurchase activities.

In May 2026, the company did not repurchase any shares through the block trading system of the Shanghai Stock Exchange.

As of May 31, 2026, the cumulative number of shares repurchased under the current buyback program via the block trading system on the Shanghai Stock Exchange reached 12,056,200 shares.

This repurchased volume represents approximately 0.18% of the company's total share capital.

The highest price paid per share was RMB 70.00, while the lowest price paid was RMB 53.52 per share.

The total amount paid for the repurchases was RMB 771.98 million, excluding transaction costs.